Tony Randgard writes:
In April, the University of Minnesota’s Psychiatry Department Chairman stepped down and psychiatric drug studies were halted, in the wake of a state report criticizing the school’s role in the suicide of patient Dan Markingson. Against his mothers’ wishes, the 27-year-old Markingson had been enrolled in a 2004 clinical trial for antipsychotic drugs. This week the University approved sweeping changes to protect human subjects involved in medical trials. In retrospect, we wonder what took so long? We harken back to a surreal winter in 1936 when the U of M was doling out free breakfast and lunch amphetamines to its Psychology students — in another very special trial.
The rest of the story is in Minnesota Connected.